IGM Biosciences, Inc.
IGMS
$1.22
$0.032.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 183.79M | 218.79M | 256.38M | 293.77M | 337.68M |
| Total Receivables | 800.00K | 1.00M | 900.00K | 900.00K | 800.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.87M | 9.65M | 8.45M | 7.76M | 8.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 167.00K | 190.00K | 289.00K | 325.00K | 592.00K |
| Total Current Assets | 193.62M | 229.63M | 266.02M | 302.75M | 347.60M |
|
|
|||||
| Total Current Assets | 193.62M | 229.63M | 266.02M | 302.75M | 347.60M |
| Net Property, Plant & Equipment | 71.03M | 73.74M | 69.05M | 71.77M | 74.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.06M | 1.14M | 1.43M | 1.61M | 1.81M |
| Total Assets | 265.71M | 304.51M | 336.50M | 376.13M | 423.41M |
|
|
|||||
| Total Accounts Payable | 983.00K | 3.55M | 3.26M | 4.00M | 1.33M |
| Total Accrued Expenses | 26.88M | 31.07M | 26.46M | 23.65M | 31.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.12M | 6.70M | 5.94M | 6.63M | 5.83M |
| Total Finance Division Other Current Liabilities | 2.65M | 2.65M | 2.00M | 3.66M | 3.78M |
| Total Other Current Liabilities | 2.65M | 2.65M | 2.00M | 3.66M | 3.78M |
| Total Current Liabilities | 37.64M | 43.96M | 37.66M | 37.93M | 42.48M |
|
|
|||||
| Total Current Liabilities | 37.64M | 43.96M | 37.66M | 37.93M | 42.48M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 38.07M | 39.16M | 33.44M | 34.30M | 34.67M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 141.84M | 142.44M | 143.05M | 142.65M | 143.02M |
| Total Liabilities | 217.54M | 225.56M | 214.14M | 214.88M | 220.18M |
|
|
|||||
| Common Stock & APIC | 1.07B | 1.06B | 1.04B | 1.03B | 1.02B |
| Retained Earnings | -1.02B | -980.39M | -918.96M | -871.06M | -821.24M |
| Treasury Stock & Other | 159.00K | 421.00K | -195.00K | -128.00K | 151.00K |
| Total Common Equity | 48.17M | 78.95M | 122.36M | 161.25M | 203.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.17M | 78.95M | 122.36M | 161.25M | 203.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.17M | 78.95M | 122.36M | 161.25M | 203.23M |
|
|
|||||